Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 9.28
+0.27 (2.94%)
Apr 8, 2026, 11:39 AM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 452.31 million as of April 7, 2026. Its market cap has decreased by -23.90% in one year.
Market Cap
452.31M
Enterprise Value
219.63M
Revenue
96.30M
Ranking
n/a
PE Ratio
14.00
Stock Price
9.28
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 452.31M, an increase of 8,555.52%. That is a compound annual growth rate of 19.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 452.81M | -27.61% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.52B |
| Clarity Pharmaceuticals | 1.17B |
| PYC Therapeutics | 1.10B |
| Opthea | 738.77M |
| Racura Oncology | 479.29M |
| Tetratherix | 220.32M |
| Orthocell | 218.40M |
| Starpharma Holdings | 210.07M |